baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

Incyte Corporation/ US45337C1027 /

1/10/2025 9:13:18 PM	Chg. -2.5800	Volume	Bid1/10/2025	Ask1/10/2025	Market Capitalization	Dividend Y.	P/E Ratio
70.5500USD	-3.53%	1.13 mill. Turnover: 56.63 mill.	70.5400Bid Size: 400	70.6200Ask Size: 400	13.55 bill.USD	-	26.34

Newsfile Corp 11/22/2024 SEC Announces Enforcement Results for Fiscal Year 2024

TeleTrader 11/19/2024 US opens sharply lower as geopolitics weigh on markets

GlobeNewswire 8/27/2024 Alex Bastian joins Memo Therapeutics AG as VP Commercial Strategy

GlobeNewswire 8/16/2024 China Medical System （00867） Released its 2024 Interim Results: Steady Increase in Revenue and Profi...

GlobeNewswire 8/6/2024 MacroGenics Provides Update on Corporate Progress, Second Quarter 2024 Financial Results

GlobeNewswire 8/1/2024 Merus Announces Financial Results for the Second Quarter 2024 and Provides Business Update

GlobeNewswire 7/30/2024 MacroGenics Announces Achievement of $100 Million in Milestones Related to Retifanlimab Collaboratio...

Newsfile Corp 7/17/2024 Analysts Hunt for Undervalued Biotech Stocks

TeleTrader 7/9/2024 US closes mostly higher after Fed's chair testimony

GlobeNewswire 6/25/2024 China Medical System Completes Dosing of the First Subject in Phase III Bridging Trial of Ruxolitini...

GlobeNewswire 5/29/2024 Lynch Carpenter Investigates Claims in Cencora, Inc. Data Breach

GlobeNewswire 5/28/2024 Keros Therapeutics Appoints Jean-Jacques Bienaimé to its Board of Directors

GlobeNewswire 5/9/2024 MacroGenics Provides Update on Corporate Progress, First Quarter 2024 Financial Results and Interim ...

GlobeNewswire 5/8/2024 Merus Announces Financial Results for the First Quarter 2024 and Provides Business Update

GlobeNewswire 4/30/2024 Akero Therapeutics Appoints Scott Gangloff as Chief Technology Officer

GlobeNewswire 4/2/2024 HUTCHMED and Innovent Jointly Announce NDA Acceptance in China for Fruquintinib Combination with Sin...

GlobeNewswire 4/1/2024 CMS and Incyte Announce Collaboration and License Agreement for Povorcitinib in China and Southeast ...

GlobeNewswire 2/28/2024 Merus Announces Financial Results for the Fourth Quarter and Full Year 2023 and Provides Business Up...

GlobeNewswire 1/9/2024 Global Oncology Cancer Drugs Market Revenue Projected To Surpass $289 Billion By 2030

TeleTrader 12/12/2023 Wall Street closes higher after inflation report

GlobeNewswire 12/9/2023 CURE Media Group announces winners of the 2023 MPN Heroes® Recognition Program

GlobeNewswire 11/16/2023 CURE Media Group® announces Jane Fonda as keynote speaker for the 2023 MPN Heroes® recognition progr...

GlobeNewswire 11/2/2023 Merus Announces Financial Results for the Third Quarter 2023 and Provides Business Update

GlobeNewswire 10/23/2023 Elevar Therapeutics Names Brian Cunningham Vice President of Sales and Kenneth Rankin Vice President...

Incyte Corporation/ US45337C1027 /

If you wish to receive reply to your feedback, please provide your email address.